These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prostatic carcinoma and benign prostatic hyperplasia: correlation of high-resolution MR and histopathologic findings. Schiebler ML; Tomaszewski JE; Bezzi M; Pollack HM; Kressel HY; Cohen EK; Altman HG; Gefter WB; Wein AJ; Axel L Radiology; 1989 Jul; 172(1):131-7. PubMed ID: 2472644 [TBL] [Abstract][Full Text] [Related]
4. Prostatic carcinoma and benign prostatic hyperplasia: inability of MR imaging to distinguish between the two diseases. Ling D; Lee JK; Heiken JP; Balfe DM; Glazer HS; McClennan BL Radiology; 1986 Jan; 158(1):103-7. PubMed ID: 2416005 [TBL] [Abstract][Full Text] [Related]
5. The abnormal prostate: MR imaging at 1.5 T with histopathologic correlation. Carrol CL; Sommer FG; McNeal JE; Stamey TA Radiology; 1987 May; 163(2):521-5. PubMed ID: 2436253 [TBL] [Abstract][Full Text] [Related]
6. Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. Jager GJ; Ruijter ET; van de Kaa CA; de la Rosette JJ; Oosterhof GO; Thornbury JR; Barentsz JO AJR Am J Roentgenol; 1996 Apr; 166(4):845-52. PubMed ID: 8610561 [TBL] [Abstract][Full Text] [Related]
7. Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Kurhanewicz J; Vigneron DB; Nelson SJ; Hricak H; MacDonald JM; Konety B; Narayan P Urology; 1995 Mar; 45(3):459-66. PubMed ID: 7533458 [TBL] [Abstract][Full Text] [Related]
8. Endoscopic laser ablation of the prostate: MR appearances during and after treatment and their relation to clinical outcome. deSouza NM; Flynn RJ; Coutts GA; Gilderdale DJ; Hall AS; Puni R; Chui M; Harris DN; Kiely EA AJR Am J Roentgenol; 1995 Jun; 164(6):1429-34. PubMed ID: 7538727 [TBL] [Abstract][Full Text] [Related]
10. Determining the volume of prostatic carcinoma: value of MR imaging with an external-array coil. Sommer FG; Nghiem HV; Herfkens R; McNeal J; Low RN AJR Am J Roentgenol; 1993 Jul; 161(1):81-6. PubMed ID: 8517328 [TBL] [Abstract][Full Text] [Related]
11. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Kurhanewicz J; Vigneron DB; Hricak H; Narayan P; Carroll P; Nelson SJ Radiology; 1996 Mar; 198(3):795-805. PubMed ID: 8628874 [TBL] [Abstract][Full Text] [Related]
12. Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging. Chen M; Hricak H; Kalbhen CL; Kurhanewicz J; Vigneron DB; Weiss JM; Carroll PR AJR Am J Roentgenol; 1996 May; 166(5):1157-63. PubMed ID: 8615261 [TBL] [Abstract][Full Text] [Related]
13. Pathologic characterization of human prostate tissue with proton MR spectroscopy. Swindle P; McCredie S; Russell P; Himmelreich U; Khadra M; Lean C; Mountford C Radiology; 2003 Jul; 228(1):144-51. PubMed ID: 12832578 [TBL] [Abstract][Full Text] [Related]
14. [Clinical use of endorectal coil MR in the study of prostatic pathology with special reference to hyperplasia and carcinoma]. Gualdi GF; Polettini E; Casciani E Clin Ter; 1996; 147(1-2):51-66. PubMed ID: 8767956 [TBL] [Abstract][Full Text] [Related]
15. Benign prostatic hyperplasia: value of MR imaging for determining histologic type. Ishida J; Sugimura K; Okizuka H; Kaji Y; Moriyama M; Nagaoka S; Mizutani M; Ishida T Radiology; 1994 Feb; 190(2):329-31. PubMed ID: 7506836 [TBL] [Abstract][Full Text] [Related]
16. Noise-reduced prostatic MR imaging. Work in progress. Sommer G; Brosnan T; Cao Q; Nishimura D; Macovski A; McNeal J Radiology; 1988 Nov; 169(2):347-50. PubMed ID: 2459726 [TBL] [Abstract][Full Text] [Related]
17. Carcinoma of the prostate: MR images obtained with body coils do not accurately reflect tumor volume. Quint LE; Van Erp JS; Bland PH; Mandell SH; Del Buono EA; Grossman HB; Glazer GM; Gikas PW AJR Am J Roentgenol; 1991 Mar; 156(3):511-6. PubMed ID: 1899746 [TBL] [Abstract][Full Text] [Related]
18. Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy. Wang L; Mazaheri Y; Zhang J; Ishill NM; Kuroiwa K; Hricak H Radiology; 2008 Jan; 246(1):168-76. PubMed ID: 18024440 [TBL] [Abstract][Full Text] [Related]
19. Differentiation of transitional zone prostate cancer from benign hyperplasia nodules: evaluation of discriminant criteria at multiparametric MRI. Chesnais AL; Niaf E; Bratan F; Mège-Lechevallier F; Roche S; Rabilloud M; Colombel M; Rouvière O Clin Radiol; 2013 Jun; 68(6):e323-30. PubMed ID: 23528164 [TBL] [Abstract][Full Text] [Related]
20. [Magnetic resonance imaging in the diagnosis of prostatic carcinoma and benign hyperplasia]. Fujiwara K; Isaka S; Shimazaki J Nihon Hinyokika Gakkai Zasshi; 1989 Sep; 80(9):1336-42. PubMed ID: 2480470 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]